Condition
Locally Advanced Hepatocellular Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Locally Advanced Hepatocellular Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (4), Belgium (1)). By phase: Phase 2 (2), Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Locally Advanced Hepatocellular Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using Holmium-166 radioembolization to treat liver cancer | — | Brussels | Recruiting | Mar 12, 2025 |
| Testing lower doses of atezolizumab for cancer treatment | Phase 1 | Bethesda, Maryland | Recruiting | Oct 4, 2023 |
| Using olanzapine to help cancer patients regain appetite and manage weight loss | Phase 2 | Portland, Oregon | Recruiting | Jan 30, 2023 |
| Personalized vaccine combined with pembrolizumab for advanced solid tumors | Phase 1/2 | Jacksonville, Florida | Recruiting | Mar 8, 2022 |
| Combining atezolizumab with a multi-kinase inhibitor for advanced liver cancer treatment | Phase 2 | Scottsdale, Arizona and 15 other locations | Recruiting | Dec 23, 2021 |
All recruiting trials (5)
-
Using Holmium-166 radioembolization to treat liver cancer
This study is testing if a new type of targeted radiation treatment called Holmium-166 can help people with advanced liver cancer feel better and live longer.
-
Testing lower doses of atezolizumab for cancer treatment
This study is testing whether lower doses of atezolizumab can effectively treat adults with advanced cancer while causing fewer side effects.
-
Using olanzapine to help cancer patients regain appetite and manage weight loss
This study is testing if the medication olanzapine can help cancer patients who are losing weight and have a poor appetite feel better and gain weight while they are receiving treatment.
-
Personalized vaccine combined with pembrolizumab for advanced solid tumors
This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.
-
Combining atezolizumab with a multi-kinase inhibitor for advanced liver cancer treatment
This study is testing if adding atezolizumab to either cabozantinib or lenvatinib can help people with advanced liver cancer live longer and feel better compared to just taking the multi-kinase inhibitor alone.
Related topics
Quick answers
How many Locally Advanced Hepatocellular Carcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.